Hematospermia: Should You Be Worried About Bloody Semen?

Published: Jun 16, 2024

Hematospermia, or bloody semen, is a rare condition often alarming to those who experience it, but it is usually harmless. This article explores the causes, evaluation, and treatment options for hematospermia.

What Causes Hematospermia?

The most common cause of hematospermia is undergoing a prostate biopsy, affecting over 80% of men post-procedure. Other causes include radiation therapy for prostate cancer, vasectomy, and infections like sexually transmitted infections (STIs). In men over 40, genitourinary cancers are considered, though they are rare.

How Is It Evaluated?

A thorough evaluation of hematospermia includes a medical history, physical examination, and urinalysis. Further tests, like transrectal ultrasound, are recommended if the condition persists for over a month. In older men, a more detailed evaluation might be considered due to a slightly higher risk of prostate cancer.

Hematospermia, or bloody semen, is a condition that can be alarming but is usually harmless. It is often caused by procedures like prostate biopsies, radiation therapy, or infections.

Treatment and Management Strategies

Most cases of hematospermia resolve on their own without specific treatment. Reassurance is crucial, especially if the condition follows a procedure like a prostate biopsy. If an infection or other treatable condition is found, appropriate treatment should be administered.

Frequently Asked Questions

It is almost never a sign of cancer, especially in younger patients.

It typically lasts three to four weeks.

No, extensive evaluation is usually not needed unless symptoms persist.

Yes, most cases resolve spontaneously without treatment.

Key Takeaways

While hematospermia can be alarming, it is typically harmless and resolves on its own.

Get started on understanding your symptoms and consult with Doctronic for personalized advice.

Related Articles

References

Ahmad I, Krishna NS. Hemospermia. J Urol 2007; 177:1613.

Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate. Urology 2002; 60:826.

Always discuss health information with your healthcare provider.